Riverview Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15K | Sell |
6
-80
| -93% | -$42K | ﹤0.01% | 212 |
|
|
2025
Q1 | $54.5K | Hold |
86
| – | – | 0.05% | 212 |
|
|
2024
Q4 | $61.3K | Sell |
86
-24
| -22% | -$17.1K | 0.06% | 203 |
|
|
2024
Q3 | $116K | Buy |
110
+2
| +2% | +$2.1K | 0.1% | 152 |
|
|
2024
Q2 | $114K | Buy |
108
+34
| +46% | +$35.7K | 0.11% | 145 |
|
|
2024
Q1 | $71.2K | Buy |
+74
| New | +$71.2K | 0.05% | 200 |
|
|
2023
Q4 | – | Sell |
-74
| Closed | -$60.9K | – | 515 |
|
|
2023
Q3 | $60.9K | Hold |
74
| – | – | 0.05% | 211 |
|
|
2023
Q2 | $53.2K | Hold |
74
| – | – | 0.05% | 200 |
|
|
2023
Q1 | $60.8K | Hold |
74
| – | – | 0.06% | 185 |
|
|
2022
Q4 | $53K | Hold |
74
| – | – | 0.05% | 209 |
|
|
2022
Q3 | $51K | Hold |
74
| – | – | 0.05% | 203 |
|
|
2022
Q2 | $44K | Hold |
74
| – | – | 0.04% | 231 |
|
|
2022
Q1 | $52K | Buy |
+74
| New | +$52K | 0.04% | 217 |
|